Marijuana rescheduling moves businesses into ‘uncharted territory’

Mon, May 20

“We’ve never had a situation where a substance has been moved from schedule one to another schedule of the CSA prior to that substance going through a traditional FDA market approval process and having that substance be approved.” #neveradullmoment https://t.co/u0GWIey5Ra

7829

Marijuana business owners hoping to benefit from the Biden administration’s move to reschedule the drug may be in for disappointment, according to experts. The administration announced plans …

Discover